From Ozempic to BPC-157, graded on the evidence
48 peptides, approved or not, with their risks, what users report and the law where you live. Nothing here is for sale.
FilterLiver
Body part
Whole-body effect
Liver 6 peptides
Liver fat and fatty liver disease (MASH).
Sort by
SemaglutideFatty liver with scarring (MASH)ProvenPrescriptionVery highWikipedia attention: Very high. Falling. Data through Sep 2026TirzepatideFatty liver disease (MASH)SupportedPrescriptionVery highWikipedia attention: Very high. Steady. Data through Sep 2026TesamorelinLiver fat in people with HIVSupportedPrescriptionModerateWikipedia attention: Moderate. Steady. Data through Sep 2026PemvidutideUpcomingFatty liver disease (MASH)SupportedTrials onlyVery lowWikipedia attention: Very low. Falling. Data through Sep 2026SurvodutideUpcomingFatty liver disease (MASH)SupportedTrials onlyVery lowWikipedia attention: Very low. Falling. Data through Sep 2026RetatrutideUpcomingLiver fatEarlyTrials onlyVery highWikipedia attention: Very high. Falling. Data through Sep 2026